Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Xencor Inc (NQ: XNCR ) 23.62 +0.44 (+1.90%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Xencor Inc < Previous 1 2 3 4 5 6 Next > Earnings Outlook For Xencor May 05, 2023 Via Benzinga Xencor to Host First Quarter 2023 Financial Results Webcast and Conference Call on May 8, 2023 May 01, 2023 From Xencor, Inc. Via Business Wire Xencor Appoints Nancy Valente, M.D., as Chief Development Officer April 26, 2023 From Xencor, Inc. Via Business Wire Xencor Highlights CD28 Bispecific Antibody Platform at AACR Annual Meeting 2023 April 17, 2023 From Xencor, Inc. Via Business Wire Why Shares of Zencor Rose This Week January 26, 2023 The clinical-stage biotech has seen its shares rise since a company presentation a few weeks ago. Via The Motley Fool Xencor's Return On Capital Employed Overview December 01, 2022 Via Benzinga 7 Biotech Stocks to Buy for 100% Returns April 09, 2023 If you can handle the risks associated with high volatility, these biotech stocks to buy might double the returns in your portfolio. Via InvestorPlace Xencor to Present Preclinical Data from Novel XmAb® CD28 Bispecific Antibody Programs at the American Association for Cancer Research Annual Meeting 2023 March 14, 2023 From Xencor, Inc. Via Business Wire Xencor Reports Fourth Quarter and Full Year 2022 Financial Results February 23, 2023 From Xencor, Inc. Via Business Wire Xencor to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on February 23, 2023 February 16, 2023 From Xencor, Inc. Via Business Wire Earnings Scheduled For February 23, 2023 February 23, 2023 Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter. Via Benzinga Top 5 Health Care Stocks That May Collapse In February February 13, 2023 The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. Via Benzinga Xencor to Present at the SVB Securities Global Biopharma Conference February 07, 2023 From Xencor, Inc. Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2023 January 31, 2023 Via Benzinga 3 Small-Cap Biopharma Stocks that Could See Big Growth in 2023 January 13, 2023 Health care stocks are trying to make a comeback and these three small-cap biopharma companies are leading the charge in some ways. Via MarketBeat Benzinga's Top Ratings Upgrades, Downgrades For January 30, 2023 January 30, 2023 Via Benzinga Xencor Highlights 2023 Corporate Priorities and Provides Portfolio Updates January 09, 2023 From Xencor, Inc. Via Business Wire Xencor to Present at the 41st Annual J.P. Morgan Healthcare Conference January 04, 2023 From Xencor, Inc. Via Business Wire Xencor Presents Data from Phase 1 Study of Plamotamab in Relapsed or Refractory Non-Hodgkin Lymphoma at the American Society of Hematology Annual Meeting December 12, 2022 From Xencor, Inc. Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022 December 06, 2022 Via Benzinga Xencor to Present at Upcoming Investor Conferences November 10, 2022 From Xencor, Inc. Via Business Wire Xencor Presents Early Clinical Data from Combination Study of Vudalimab and New Data from Multiple Preclinical-stage XmAb® Programs at the SITC Annual Meeting November 10, 2022 From Xencor, Inc. Via Business Wire Xencor Reports Third Quarter 2022 Financial Results November 07, 2022 From Xencor, Inc. Via Business Wire Xencor’s IL2-Fc Cytokine, XmAb®564, is Well-tolerated and Selectively Expands Regulatory T Cells in Phase 1a Clinical Study November 07, 2022 From Xencor, Inc. Via Business Wire Earnings Scheduled For November 7, 2022 November 07, 2022 Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is expected to report quarterly earnings at $0.13 per share on revenue of $36.34 million. Via Benzinga Xencor Earnings Preview November 04, 2022 Xencor (NASDAQ:XNCR) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that Xencor will report an... Via Benzinga Xencor to Present New Clinical Data from the Phase 1 Study of Plamotamab in Relapsed or Refractory Non-Hodgkin’s Lymphoma at the American Society of Hematology Annual Meeting November 03, 2022 From Xencor, Inc. Via Business Wire Xencor to Host Third Quarter 2022 Financial Results Webcast and Conference Call on November 7, 2022 October 31, 2022 From Xencor, Inc. Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022 October 13, 2022 Upgrades Via Benzinga Xencor to Present Seven Posters on Multiple Clinical Trials and Research-stage Programs at the SITC Annual Meeting October 05, 2022 From Xencor, Inc. Via Business Wire < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
